These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 31117372)

  • 41. Precision cut lung slices as test system for candidate therapeutics in organophosphate poisoning.
    Herbert J; Thiermann H; Worek F; Wille T
    Toxicology; 2017 Aug; 389():94-100. PubMed ID: 28743514
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The role of oxidative stress in organophosphate and nerve agent toxicity.
    Pearson JN; Patel M
    Ann N Y Acad Sci; 2016 Aug; 1378(1):17-24. PubMed ID: 27371936
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Novel bifunctional hybrid small molecule scavengers for mitigating nerve agents toxicity.
    Amitai G; Gez R; Raveh L; Bar-Ner N; Grauer E; Chapman S
    Chem Biol Interact; 2016 Nov; 259(Pt B):187-204. PubMed ID: 27129421
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Blood acylpeptide hydrolase activity is a sensitive marker for exposure to some organophosphate toxicants.
    Quistad GB; Klintenberg R; Casida JE
    Toxicol Sci; 2005 Aug; 86(2):291-9. PubMed ID: 15888665
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Preclinical and first-in-human evaluation of PRX-105, a PEGylated, plant-derived, recombinant human acetylcholinesterase-R.
    Atsmon J; Brill-Almon E; Nadri-Shay C; Chertkoff R; Alon S; Shaikevich D; Volokhov I; Haim KY; Bartfeld D; Shulman A; Ruderfer I; Ben-Moshe T; Shilovitzky O; Soreq H; Shaaltiel Y
    Toxicol Appl Pharmacol; 2015 Sep; 287(3):202-9. PubMed ID: 26051873
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cellular Nanosponges for Biological Neutralization.
    Wang S; Wang D; Duan Y; Zhou Z; Gao W; Zhang L
    Adv Mater; 2022 Apr; 34(13):e2107719. PubMed ID: 34783078
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prevention of organophosphate-induced chronic epilepsy by early benzodiazepine treatment.
    Shrot S; Ramaty E; Biala Y; Bar-Klein G; Daninos M; Kamintsky L; Makarovsky I; Statlender L; Rosman Y; Krivoy A; Lavon O; Kassirer M; Friedman A; Yaari Y
    Toxicology; 2014 Sep; 323():19-25. PubMed ID: 24881594
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reappraisal of indications and limitations of oxime therapy in organophosphate poisoning.
    Worek F; Bäcker M; Thiermann H; Szinicz L; Mast U; Klimmek R; Eyer P
    Hum Exp Toxicol; 1997 Aug; 16(8):466-72. PubMed ID: 9292287
    [TBL] [Abstract][Full Text] [Related]  

  • 49. From organophosphate poisoning to diabetes mellitus: The incretin effect.
    Rathish D; Agampodi SB; Jayasumana MACS; Siribaddana SH
    Med Hypotheses; 2016 Jun; 91():53-55. PubMed ID: 27142144
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Organophosphate-induced convulsions and prevention of neuropathological damages.
    Tuovinen K
    Toxicology; 2004 Mar; 196(1-2):31-9. PubMed ID: 15036754
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A Novel Biomimetic Nanosponge Protects the Retina from the
    LaGrow AL; Coburn PS; Miller FC; Land C; Parkunan SM; Luk BT; Gao W; Zhang L; Callegan MC
    mSphere; 2017; 2(6):. PubMed ID: 29202038
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Reversible cholinesterase inhibitors as pretreatment for exposure to organophosphates. A review.
    Lorke DE; Petroianu GA
    J Appl Toxicol; 2019 Jan; 39(1):101-116. PubMed ID: 30027640
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Developments in alternative treatments for organophosphate poisoning.
    Iyer R; Iken B; Leon A
    Toxicol Lett; 2015 Mar; 233(2):200-6. PubMed ID: 25595305
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cholinesterase reactivators and bioscavengers for pre- and post-exposure treatments of organophosphorus poisoning.
    Masson P; Nachon F
    J Neurochem; 2017 Aug; 142 Suppl 2():26-40. PubMed ID: 28542985
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Optimal choice of acetylcholinesterase reactivators for antidotal treatment of nerve agent intoxication.
    Bajgar J
    Acta Medica (Hradec Kralove); 2010; 53(4):207-11. PubMed ID: 21400978
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Organophosphate and carbamate poisoning.
    King AM; Aaron CK
    Emerg Med Clin North Am; 2015 Feb; 33(1):133-51. PubMed ID: 25455666
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Two possible orientations of the HI-6 molecule in the reactivation of organophosphate-inhibited acetylcholinesterase.
    Luo C; Leader H; Radic Z; Maxwell DM; Taylor P; Doctor BP; Saxena A
    Biochem Pharmacol; 2003 Aug; 66(3):387-92. PubMed ID: 12907237
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficacy of Recommended Prehospital Human Equivalent Doses of Atropine and Pralidoxime Against the Toxic Effects of Carbamate Poisoning in the Hartley Guinea Pig.
    Brittain MK; McGarry KG; Moyer RA; Babin MC; Jett DA; Platoff GE; Yeung DT
    Int J Toxicol; 2016 May; 35(3):344-57. PubMed ID: 27102179
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Neuronal Cellular Nanosponges for Effective Detoxification of Neurotoxins.
    Wang D; Ai X; Duan Y; Xian N; Fang RH; Gao W; Zhang L
    ACS Nano; 2022 Nov; 16(11):19145-19154. PubMed ID: 36354967
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pyridinium, imidazolium and quinuclidinium compounds: toxicity and antidotal effects against the nerve agents Tabun and Soman.
    Reiner E; Simeon-Rudolf V
    Arh Hig Rada Toksikol; 2006 Jun; 57(2):171-9. PubMed ID: 16832972
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.